Rivaroxaban

CAS366789-02-8

Rivaroxaban (CAS 366789-02-8, C19H18ClN3O5S) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of Rivaroxaban
C19H18ClN3O5S · 435.88 g/mol
CAS No.
366789-02-8
Formula
C19H18ClN3O5S
Mol. weight
435.88 g/mol

Chemical Specifications

Identifiers

CAS number 366789-02-8
Product name Rivaroxaban
Chinese name 利伐沙班
Synonyms 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide
Chinese synonyms 5-氯-N-(((5S)-2-氧代-3-(4-(3-氧代吗啉-4-基)苯基)-1,3-恶唑啉-5-基)甲基)噻吩-2-甲酰胺; 利伐沙班; 5-氯-N-[[(5S)-2-氧代-3-[4-(3-氧代-4-吗啉基)苯基]-5-恶唑基]甲基]-2-噻吩甲酰胺; 利伐沙班, 5-氯-N-(((5S)-2-氧代-3-(4-(3-氧代吗啉-4-基)苯基)-1,3-恶唑啉-5-基)甲基)噻吩-2-甲酰胺; 利伐沙班-D4; 立伐沙班; RIVAROXABAN 利伐沙班; 立伐沙班原料药
Molecular formula C19H18ClN3O5S
Molecular weight 435.88 g/mol

Physical and chemical properties

Boiling Point 396.868 ( ℃ )

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of Rivaroxaban?

The CAS Registry Number of Rivaroxaban is 366789-02-8. Rivaroxaban is also known as 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide.

What is the molecular formula and molecular weight of Rivaroxaban?

The molecular formula of Rivaroxaban is C19H18ClN3O5S, and its molecular weight is 435.88 g/mol.

How can I request a quotation for Rivaroxaban?

Send an inquiry for Rivaroxaban (CAS 366789-02-8) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for Rivaroxaban

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.